HLS Stock Overview
Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia.
Healius Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$3.96|
|52 Week High||AU$5.54|
|52 Week Low||AU$3.59|
|1 Month Change||7.03%|
|3 Month Change||-5.71%|
|1 Year Change||-21.43%|
|3 Year Change||37.50%|
|5 Year Change||13.79%|
|Change since IPO||182.86%|
Recent News & Updates
Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Healius Limited...
|HLS||AU Healthcare||AU Market|
Return vs Industry: HLS underperformed the Australian Healthcare industry which returned -4% over the past year.
Return vs Market: HLS underperformed the Australian Market which returned -7.9% over the past year.
|HLS Average Weekly Movement||4.0%|
|Healthcare Industry Average Movement||5.6%|
|Market Average Movement||10.6%|
|10% most volatile stocks in AU Market||17.5%|
|10% least volatile stocks in AU Market||4.7%|
Stable Share Price: HLS is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: HLS's weekly volatility (4%) has been stable over the past year.
About the Company
Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pathology, Imaging, and Day Hospitals. It offers diagnostic imaging services, including X-ray, ultrasound, computerized tomography, mammography, magnetic resonance imaging, nuclear medicine, positron emission tomography, and interventional radiology; and private medical laboratory and pathology services.
Healius Limited Fundamentals Summary
|HLS fundamental statistics|
Is HLS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HLS income statement (TTM)|
|Cost of Revenue||AU$1.31b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 30, 2022
|Earnings per share (EPS)||0.40|
|Net Profit Margin||9.79%|
How did HLS perform over the long term?See historical performance and comparison